Namida Lab Inc. of Fayetteville is working now to put infrastructure in place that will allow it to begin conducting COVID-19 antibody testing in early May.
Health care workers and the staff of large employers will be tested first, then the general public will be tested, the company said.
Namida Lab said it is equipped with a fully automated, high throughput laboratory that can run up to 3,000 samples per day and report results in 24 to 48 hours. The company has also dedicated its research and development team to provide the large scale COVID-19 antibody testing.
“COVID-19 came on the scene as we were readying to launch our breast cancer screening test, Melody,” CEO Omid Moghadam said in a news release. “But we have paused that project to adapt our mission and lend our help to the greater current need. As our communities look for a path to reopening, antibody testing will help us understand actual infection rates and allow individuals and businesses to make informed decisions based on that information."